Health Care

EPS for Collegium Pharmaceutical Inc (COLL) Expected At $

Year to Date (YTD) performance of Collegium Pharmaceutical, Inc. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.14 average brokerage recommendation.

Several analysts have released their opinion on Collegium Pharmaceutical, Inc. Needham & Company LLC reiterated a "buy" rating and issued a $25.00 price target on shares of Collegium Pharmaceutical in a research report on Friday, October 6th. The firm has "Buy" rating by Jefferies given on Wednesday, August 16. Finally, Zacks Investment Research upgraded Collegium Pharmaceutical from a "sell" rating to a "hold" rating in a research report on Monday, August 14th. Cadian Capital Management, LLC is the second biggest holder with 2 million shares now valued at 28.25 million whilst Eventide Asset Management, LLC has 2 million shares valued at 27.62 million.

Collegium Pharmaceutical (NASDAQ:COLL) opened at $10.10 on Wednesday. (COLL) is -35.13 percent while its Performance (Week) is -2.23 percent and Performance (month) is at -14.26 percent.

At the end of 06/30/2017 reporting period, 44 institutional holders increased their position in Collegium Pharmaceutical, Inc. Insider ownership during the latest quarter decreased by a net of 0 shares, indicating that COLL's key executives are feeling more bearish about the stock than they did three months ago. Collegium Pharmaceutical had a negative net margin of 1,319.39% and a negative return on equity of 93.73%.

Collegium Pharmaceutical, Inc. has its outstanding Shares of 29.44 Million.

ILLEGAL ACTIVITY WARNING: "Collegium Pharmaceutical (NASDAQ:COLL) Receives News Impact Score of 0.26" was reported by TrueBlueTribune and is the property of of TrueBlueTribune. Jefferies has "Buy" rating and $1500 target. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & global trademark & copyright law. Jefferies has "Buy" rating and $15.0 target. After posting $-0.72 EPS for the previous quarter, Collegium Pharmaceutical Inc's analysts now forecast 2.78 % negative EPS growth. The idea that stock performance can best be predicted by analyzing past trading data is a widely held view among financial professionals. Rice Hall James & Associates LLC acquired a new position in shares of Collegium Pharmaceutical during the third quarter valued at approximately $592,000. 12, 2015, the great number of shares acquired came courtesy the Director, 10% Owner; Heron Patrick J added a total of 150,000 shares at an average price of $12, amounting to approximately $1,800,000. Investors will be keeping a close eye on the stock during this session to see if the upward trend will remain throughout the day.

Collegium Pharmaceutical, Inc is a specialty pharmaceutical company. The Firm is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS.



Like this

loading...
loading...

Latest


10 November 2017
Take care - severe weather on the way
A second warning of possible severe thunderstorms with strong winds and a possibility of hail has also been issued for north-western KZN from 1pm to 9pm this evening.

10 November 2017
CAPROCK Group Inc. Purchases New Position in Target Corporation (TGT)
Nomura set a $75.00 price target on Target Corp. and gave the company a "hold" rating in a research note on Thursday, August 18th. The company has a market capitalization of $32,300.00, a PE ratio of 11.74, a P/E/G ratio of 2.74 and a beta of 0.63.

10 November 2017
CBS approved for Network Ten takeover
However, the federal government recently passed controversial legislation permitting ownership of media across several platforms. The deal needs final clearance (widely expected) from the Australian Securities and Investment Commission.

10 November 2017
Death toll from typhoon Damrey in Vietnam reaches 106
Typhoon Damrey, Vietnam's deadliest storm this year, has killed at least 106 people, injuring 197 others, and leaving 25 missing. It will bring together US President Donald Trump, China's Xi Jinping and Russia's Vladimir Putin, among other leaders.

10 November 2017
What's Real Worth Of Exxon Mobil Corporation (XOM), Switch, Inc. (SWCH)
The oil and gas company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.04. Loomis Sayles And LP holds 0% of its portfolio in Masco Corp (NYSE:MAS) for 999 shares. 200 are owned by Sandy Spring Bankshares.

10 November 2017
Tearful meeting for pair forever linked by face transplant
Andy says the transplant has transformed his life. 'I wanted to show you that your gift will not be wasted, ' he told Lilly. Lilly had feared seeing Calen's face on another man for the possible reminders of the suicide that ended his life.

10 November 2017
India 'deplores' UN Rapporteur's comments on Mahatma Gandhi
It denied the UNSR's allegations, citing a report by a private organisation, about the lack of toilets in government schools. UNSR alleged that human rights principles have not been properly addressed in India's water and sanitation programmes.

10 November 2017
Torso found in Oshawa identified as missing 18-year-old woman
Hache had had a challenging childhood, but had begun to establish herself, and had her own income and apartment, Meeldyk said. Police in Oshawa have named the person whose torso was found in Lake Ontario September 11 as Rori Hache, 18, of Oshawa.

10 November 2017
Popular Ex-Boxer Mike Tyson Barred From Entering Chile
This isn't the first time he has been barred from a country for his lengthy rap sheet. Tyson was placed on a flight home, according the Investigative Police (PDI).

10 November 2017
Rangers: Dick Advocaat thinks Aberdeen boss Derek McInnes is ready for Ibrox
RYAN JACK has insisted he won't have a problem if Derek McInnes is named Rangers boss. He wanted to keep me as a part of it'.